Roche Palo Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ROCHE PALO, and what generic and branded alternatives to ROCHE PALO drugs are available?
ROCHE PALO has thirteen approved drugs.
Summary for Roche Palo
US Patents: | 0 |
Tradenames: | 7 |
Ingredients: | 8 |
NDAs: | 13 |
Patent Litigation for Roche Palo: | See patent lawsuits for Roche Palo |
Drugs and US Patents for Roche Palo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche Palo | CELLCEPT | mycophenolate mofetil | CAPSULE;ORAL | 050722-001 | May 3, 1995 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche Palo | CELLCEPT | mycophenolate mofetil | TABLET;ORAL | 050723-001 | Jun 19, 1997 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche Palo | CELLCEPT | mycophenolate mofetil hydrochloride | INJECTABLE;INJECTION | 050758-001 | Aug 12, 1998 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche Palo | FEMSTAT | butoconazole nitrate | CREAM;VAGINAL | 019215-001 | Nov 25, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Roche Palo | CELLCEPT | mycophenolate mofetil | FOR SUSPENSION;ORAL | 050759-001 | Oct 1, 1998 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche Palo | AEROBID | flunisolide | AEROSOL, METERED;INHALATION | 018340-001 | Aug 17, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-001 | Mar 24, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Roche Palo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche Palo | CELLCEPT | mycophenolate mofetil | FOR SUSPENSION;ORAL | 050759-001 | Oct 1, 1998 | 4,753,935 | ⤷ Sign Up |
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-002 | Oct 31, 1991 | 4,051,141 | ⤷ Sign Up |
Roche Palo | CYTOVENE | ganciclovir | CAPSULE;ORAL | 020460-001 | Dec 22, 1994 | 4,507,305 | ⤷ Sign Up |
Roche Palo | CYTOVENE | ganciclovir | CAPSULE;ORAL | 020460-001 | Dec 22, 1994 | 4,642,346 | ⤷ Sign Up |
Roche Palo | CELLCEPT | mycophenolate mofetil | TABLET;ORAL | 050723-001 | Jun 19, 1997 | 4,753,935 | ⤷ Sign Up |
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-001 | Mar 24, 1993 | 4,591,592 | ⤷ Sign Up |
Roche Palo | AEROBID | flunisolide | AEROSOL, METERED;INHALATION | 018340-001 | Aug 17, 1984 | 4,933,168 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ROCHE PALO drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | For Oral Suspension | 200 mg/mL | ➤ Subscribe | 2011-03-25 |
Similar Applicant Names
Here is a list of applicants with similar names.